• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Kodak names new execs

Article

Eastman Kodak (Rochester, NY) has promoted Michael L. Marsh to general manager of digital output in the company's health imaging group. Marsh will replace John Farrell, who will become worldwide GM for growth services, a new role in health imaging's

Eastman Kodak (Rochester, NY) has promoted Michael L. Marsh to general manager of digital output in the company's health imaging group. Marsh will replace John Farrell, who will become worldwide GM for growth services, a new role in health imaging's global services organization. Holly Ferrell was appointed earlier as chief marketing officer and divisional vice president of health imaging.

Marsh will be responsible for the development and manufacturing of health imaging's market-leading DryView laser imagers. He is currently GM of the capture business within the company's commercial imaging group, responsible for the design, manufacture, and marketing of high-speed document scanners.

Ferrell directs worldwide product and service marketing strategies, working closely with health imaging's strategic product groups and regional organizations. She oversees product marketing, market research, training and education, and global communications.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.